Loading…
Underlying
Underlying Price
$39.57
Type
Put
Strike
39
Expiration
Oct 16, 2026
DTE
9d
Moneyness
OTM
Intrinsic
$0.00
EWTX 39 Put Across Expirations
| Expiration | DTE | Last | Change | Vol | Open Int |
|---|---|---|---|---|---|
| Oct 16, 2026 | 9d | $1.44 | -22.16% | 7 | 33 |
| Nov 20, 2026 | 44d | — | — | 0 | 0 |
| Dec 18, 2026 | 72d | — | — | 0 | 0 |
| Jan 15, 2027 | 100d | $5.70 | +35.71% | 2 | 4 |
| Feb 19, 2027 | 135d | — | — | 0 | 0 |
| May 21, 2027 | 226d | — | — | 0 | 0 |
EWTX Nearby Strikes · Oct 16, 2026
| Strike | Last | Change | Vol | Open Int | Moneyness |
|---|---|---|---|---|---|
| 33 P | $0.34 | -69.64% | 1 | 0 | OTM |
| 34 P | $0.57 | +0.00% | 10 | 10 | OTM |
| 35 P | $0.70 | -30.00% | 13 | 3,010 | OTM |
| 36 P | $0.93 | +34.78% | 3 | 5 | OTM |
| 37 P | $1.50 | +87.50% | 13 | 16 | OTM |
| 38 P | $1.35 | +3.85% | 1 | 46 | OTM |
| 39 P | $1.44 | -22.16% | 7 | 33 | OTM |
| 40 P | $1.50 | -40.00% | 1 | 171 | ITM |
| 41 P | $1.90 | +10.47% | 15 | 15 | ITM |
| 42 P | $2.47 | -26.27% | 2 | 43 | ITM |
| 43 P | $4.15 | +5.06% | 1 | 13 | ITM |
| 44 P | — | — | 0 | 0 | ITM |
| 45 P | — | — | 0 | 0 | ITM |
EWTX Profile
edgewise therapeutics is a biotechnology company focused on developing novel therapies for diseases involving skeletal muscle. the company is headquartered in boulder, co and received its series a financing from orbimed.